Yasuko Rikihisa, PhD
Specialties and Expertise
- Vector-borne zoonoses; Ehrlichia, Anaplasma, Neorickettsia
Education
- MS and PhD: University of Tokyo
- Postdoc: Harvard Medical School
Select Awards, Achievements, and Publications
- Budachetri K, Lin M, Chien RC, Zhang W, Brock GN, Rikihisa Y. Efficacy and immune correlates of OMP-1B and VirB2-4 vaccines for protection of dogs from tick transmission of Ehrlichia chaffeensis. mBio. 2022;in press.
- Budachetri K, Lin M, . . . , Rikihisa Y. Real-time PCR differential detection of Neorickettsia findlayensis and N. risticii in cases of Potomac horse fever. J Clin Microbiol. 2022;60(7):e0025022.
- Huang W, Xiong Q, Lin M, Rikihisa Y. Anaplasma phagocytophilum hijacks flotillin and NPC1 complex to acquire intracellular cholesterol for proliferation, which can be inhibited with ezetimibe. mBio. 2021;12(5):e0229921.
- Zhang W, Lin M, . . . , Rikihisa Y. An intracellular nanobody targeting T4SS effector inhibits Ehrlichia infection. Proc Natl Acad Sci USA. 2021;118(18):e2024102118.
- UK Kennel Club Charitable Trust International Canine Health Award, 2018
Manual Chapters and Commentaries
